{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-044598","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2022-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.492189+00:00","generated_at":"2026-06-21T09:15:26.594140+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Eterna Therapeutics terminates San Diego office lease; consolidates R&D to Cambridge, MA","bullets":["Entered lease termination agreement for 5,193 sq ft office at 10355 Science Center Drive, San Diego.","Lease will terminate if Landlord re-lets premises by Jan 15, 2023; effective Feb 28, 2023.","Termination fee of $100,000 payable in two installments; otherwise lease expires June 2027.","Termination aligns with previously announced decision in Q2 2022 to consolidate R&D in Cambridge, MA."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-044598","json":"https://secwatch.observer/filing/0001140361-22-044598.json","markdown":"https://secwatch.observer/filing/0001140361-22-044598.md","text":"https://secwatch.observer/filing/0001140361-22-044598.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000114036122044598/0001140361-22-044598-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000114036122044598/brhc10045139_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T09:15:26.594140+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5fbd8d996be3d371ac53159bb95797c4ea8dcd02","claim":"Ernexa Therapeutics Inc. terminated Termination Agreement with Torrey Pines Science Center Limited Partnership valued at $100,000 (effective 2022-11-30).","evidence_excerpt":"On November 30, 2022, Eterna Therapeutics Inc., a Delaware corporation (the “ Company ”), entered into a lease termination agreement (the “ Termination Agreement ”) with Torrey Pines Science Center Limited Partnership, a Delaware limited partnership (“ Landlord ”), to terminate that certain lease agreement (the “ Lease ”), dated as of March 31, 2022","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122044598/0001140361-22-044598-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"lease"},{"label":"Counterparty","value":"Torrey Pines Science Center Limited Partnership"},{"label":"Value","value":"$100,000"},{"label":"Effective","value":"2022-11-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}